What are the different types of dialysis modalities for end‑stage renal disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Dialysis for End-Stage Renal Disease

The primary dialysis modalities for end-stage renal disease are hemodialysis (HD), peritoneal dialysis (PD), and continuous renal replacement therapy (CRRT), with HD and PD being the mainstay chronic options and CRRT reserved for critically ill patients. 1

Primary Chronic Dialysis Modalities

Hemodialysis (HD)

Intermittent hemodialysis is the most commonly used extracorporeal kidney replacement therapy modality for patients with advanced chronic kidney disease in kidney failure. 1 This modality operates through diffusion-based clearance and is typically performed three times weekly for 3-4 hours per session. 1

HD can be delivered in two settings:

  • In-center hemodialysis: Performed at dialysis facilities through vascular access via arteriovenous fistula (requires months to mature), arteriovenous graft (usable within 24 hours), or central venous catheter (immediately usable but highest infection risk). 2
  • Home hemodialysis: Associated with improved survival and quality of life compared to other dialysis modes, offering greater patient autonomy and treatment satisfaction. 1, 3

Peritoneal Dialysis (PD)

PD uses the patient's own peritoneal membrane as the dialyzer, with dialysate fluid instilled into the peritoneal cavity to achieve solute exchange between blood in peritoneal capillaries and dialysis fluid. 1, 4 This modality provides continuous clearance and is performed at home. 2

PD has two primary variants:

  • Continuous ambulatory peritoneal dialysis (CAPD): Based on daily manual exchanges performed by the patient at home. 1
  • Automated peritoneal dialysis (APD): Exchanges performed by a simplified machine, usually at home during nighttime. 1

Specialized Modalities for Critically Ill Patients

Continuous Renal Replacement Therapy (CRRT)

CRRT is the preferred modality for hemodynamically unstable patients or those with acute kidney injury requiring intensive care. 1 This therapy runs 24 hours daily and provides superior hemodynamic stability, slower solute shifts, and better tolerance of fluid removal compared to intermittent HD. 1

Prolonged Intermittent Kidney Replacement Therapy (PIKRT)

PIKRT represents "hybrid" therapy combining characteristics of intermittent and continuous kidney replacement therapy, with prolonged duration (8-12 hours) and increased frequency. 1 No clear advantage has been demonstrated for CRRT over PIKRT in critically ill patients. 1

Intermittent Hemofiltration and Hemodiafiltration

Intermittent hemofiltration can be used in hypotension-prone patients with kidney failure on chronic kidney replacement therapy, achieving clearance through convection. 1 In most cases, hemodialysis and hemofiltration are combined in the same session (hemodiafiltration). 1

Clinical Outcomes and Modality Selection

Clinical outcomes across all dialysis modalities are largely similar, but specific clinical measures may favor one modality over another. 1 The choice among available modalities is preference-sensitive, requiring consideration of quality of life, life goals, clinical characteristics, family or care-partner support, and living environment. 1

When to Choose Peritoneal Dialysis

PD should be considered for patients with:

  • Severe cardiac disease or congestive heart failure requiring better hemodynamic stability, as PD avoids rapid fluid and electrolyte shifts that occur with HD. 4
  • Extensive vascular disease or inability to establish vascular access. 4
  • Desire for greater patient autonomy and treatment flexibility. 1
  • Need for better preservation of residual kidney function, which is critical for survival and quality of life. 4

Absolute contraindications to PD include:

  • Documented loss of peritoneal function or extensive abdominal adhesions limiting dialysate flow. 4

Relative contraindications to PD include:

  • Inflammatory or ischemic bowel disease, frequent diverticulitis episodes, morbid obesity, or severe malnutrition. 4

When to Choose Hemodialysis

HD should be considered for patients with:

  • Hemodynamic stability allowing tolerance of intermittent treatments. 1
  • Contraindications to peritoneal dialysis. 4
  • Need for more efficient solute and fluid removal than PD can provide. 5

When to Choose CRRT or PIKRT

CRRT or PIKRT should be initiated for:

  • Hemodynamically unstable patients who cannot tolerate conventional intermittent hemodialysis. 1
  • Critically ill patients with acute kidney injury requiring intensive care unit management. 1
  • Patients at high risk for dialysis disequilibrium syndrome with extremely elevated blood urea nitrogen. 6

Important Clinical Considerations

Both hemodialysis and peritoneal dialysis are equally effective long-term replacement therapies for end-stage renal disease. 1 No differences in long-term mortality rates between the two modalities have been demonstrated, though some studies suggest PD survival advantage is best at the start of dialysis (first 1.5-2 years). 2, 7

Shared decision-making between patients, care-partners, and healthcare teams is essential after high-quality education about all available modality options. 1 Everyone facing dialysis should have access to home therapy options. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Peritoneal Dialysis and Hemodialysis Comparison

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Tremors in Patients with Chronic Kidney Disease on Peritoneal Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Prevention and Management of Dialysis Disequilibrium Syndrome (DDS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the ethical and legal issues involved in Renal Replacement Therapy (RRT) for patients with End-Stage Renal Disease (ESRD)?
What are the primary treatment options for a patient with End-Stage Renal Disease (ESRD), including management of comorbid conditions and medication therapy?
What is the care plan for a patient with End-Stage Renal Disease (ESRD)?
What is permanent renal replacement therapy for patients with end-stage renal disease (ESRD)?
What is the immediate recommendation for a patient requiring renal replacement therapy due to impaired renal function?
What is the appropriate management for an adult post‑cholecystectomy patient presenting with right upper quadrant and epigastric pain, a mildly dilated common bile duct (10 mm) without obstructing stones, and elevated aspartate aminotransferase and alanine aminotransferase?
If a repeat coronary calcium (Agatston) score performed 3–5 years after the initial scan shows an increase despite the patient being on high‑intensity statin therapy with LDL‑C <50 mg/dL, what are the clinical implications and recommended management?
What is the appropriate immediate management for a patient with a urinalysis showing +1 leukocytes, positive nitrite, hematuria, and a urine culture growing Escherichia coli?
What is the first‑line treatment for an acute vaso‑occlusive sickle cell crisis?
In a patient with synovial chondromatosis and early hip osteoarthritis on tofacitinib 5 mg daily who needs hip arthroscopy in 3 months but cannot stop the JAK inhibitor due to severe groin/hip stiffness, what alternative peri‑operative management can be used until surgery?
What is the most appropriate next step in managing a patient with decompensated alcoholic cirrhosis, ascites, jaundice, peripheral edema, alkaline phosphatase 294 U/L, alanine aminotransferase 61 U/L, aspartate aminotransferase 145 U/L, and total bilirubin 12.4 mg/dL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.